David Kenigsberg, MD
Clinical Cardiac Electrophysiology · Fort Lauderdale, FLNPI 1902967144
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $778,873 of the $1,004,759 with a category attached, or 77.5%. 41 manufacturers reported payments, led by Pulse Biosciences, Inc. at 48.0% of the total. 2025 is the largest year on record at $420,215, 4.0 times the $105,309 reported in 2019. Among clinical cardiac electrophysiology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,904 payments — averaging $527.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pulse Biosciences, Inc.$483K
- Cardiofocus, Inc.$219K
- Abbott$107K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$34K
- Cvrx, Inc.$32K
- Biosense Webster, Inc.$23K
- plus $107K from 35 others
Across 65 payments — averaging $3940.58 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Cortex, Inc.$123K
- Cvrx, Inc.$60K
- Boston Scientific$34K
- Impulse Dynamics (USA) Inc.$16K
- Elutia, Inc.$11K
- Cardiofocus, Inc.$10K
- plus $3K from 3 others
What the payments were for
- Consulting fees$778,87378%
- Speaking & faculty fees$126,64613%
- Travel & lodging$38,4444%
- Food & beverage$60,7976%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CellFX$482,552
- HeartLight System$205,486
- Ensite Cardiac Mapping System$40,261
- LifeVest$32,500
- Barostim Neo System$30,301
- OPTIMIZER$26,432
- Carto 3$18,267
- PRADAXA$14,140
- EnSite Precision Cardiac Mapping System$9,077
- Accent Pacemaker$8,796
- XARELTO$8,287
- Arctic Front$7,218
- Assurity Pacemaker$6,383
- Quadra Assura CRT Defibrillator$5,821
- ENSITE$5,164
- Edwards SAPIEN 3 Transcatheter Heart Valve$5,000
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$4,025
- OPTIMIZER SMART SYSTEM$3,222
- AVEIR$2,648
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$2,500
How this compares
$1,004,759 in reported general payments places this provider in the 95th percentile of 249 clinical cardiac electrophysiology providers in Florida.
See all clinical cardiac electrophysiology providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 644 | $557,847 |
| XareltoRivaroxaban | 197 | $195,722 |
| EntrestoSacubitril/Valsartan | 75 | $79,206 |
| MultaqDronedarone Hcl | 42 | $49,641 |
| FarxigaDapagliflozin Propanediol | 51 | $36,439 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 32 | $9,268 |
| Metoprolol Succinate | 541 | $7,936 |
| Amiodarone Hcl | 200 | $3,660 |
| SotalolSotalol Hcl | 147 | $3,079 |
| Flecainide Acetate | 85 | $2,440 |
| Metoprolol Tartrate | 164 | $858 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 45 | $726 |
| Valsartan | 47 | $600 |
| Fludrocortisone Acetate | 40 | $558 |
| ClopidogrelClopidogrel Bisulfate | 44 | $471 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $952 | $557,847644 claims |
| Johnson & JohnsonXarelto | $8,904 | $195,722197 claims |
| NovartisEntresto | $260 | $79,20675 claims |
| Sanofi-aventis U.S. LLCMultaq | $5,512 | $49,64142 claims |
| AstraZenecaFarxiga | $68 | $36,43951 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 249 clinical cardiac electrophysiology providers in Florida.
Other clinical cardiac electrophysiology in Fort Lauderdale
- Jose Baez-EscuderoFort Lauderdale$196K
- Ahmed OsmanFort Lauderdale$137K
- Esteban KloostermanFort Lauderdale$116K
- Usman SiddiquiWinter Park$1.2M
- Jose Osorio FilhoMiami$1.2M
- Raul WeissMiami Beach$887K
- Naushad ShaikKissimmee$691K
- Parikshit SharmaWeston$462K
- Saumil OzaJacksonville$462K
- Brian BetenskySarasota$412K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.